EMPIRE STATE BUILDING, NEW YORK, NY
Presents T Cell Engager Data Demonstrating Deep B Cell Depletion for Autoimmune Indications
Results of Operations and Financial Condition
Other Events
News, Articles of Incorporation
Presents Positive Phase 1 Data of INB-200 in Newly Diagnosed GBM Demonstrating Prolonged Progression-Free Survival
Submission of Matters to a Vote of Security Holders
Reports First Quarter 2025 Financial Results and Recent Business Highlights
Unveils Promising New Data from Next Generation Gamma-Delta T Cell Engager (TCE) Platform at AACR 2025
Q2
Amended Annual Report
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Definitive Revised Proxy Statement